Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527 · cited 1×
“Current ideas on basal ganglia function in LID The basal ganglia comprise a complex network of parallel loops that integrate multimodal input from the cerebral cortex, basal ganglia and thalamu”
BackgroundChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Functional architecture of basal ganglia circuits: neural substrates of parallel processing
Alexander, G. E., & Crutcher, M. D. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90107-l · Cited by 4,131 · cited 1×
“The circuits that link the striatum with the output nuclei consist of the so-called 'direct' and 'indirect' pathway”
BackgroundPrimate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L., & Schwartz, J.-C. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,609
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
Parent, A., & Hazrati, L.-N. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00007-c · Cited by 2,161 · cited 1×
“The striatum receives glutamate inputs from the cerebral cortex and thalamu”
BackgroundEhringer, H., & Hornykiewicz, O. (1960) · Klinische Wochenschrift · doi:10.1007/bf01485901 · Cited by 1,867
Parkinson, J. (2002) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.14.2.223 · Cited by 1,628
Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422004 · Cited by 1,539
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“Because both the SNr and GPi provide inhibitory output to motor nuclei outside the basal ganglia (e.g., motor thalamus and brain stem locomotor regions), this mechanism is thought to contribute to the excessive motor inhibition in PD (Obeso et al., 2000; Bezard et al., 2001).”
BackgroundLoss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., & Calabresi, P. (2003) · Nature Neuroscience · doi:10.1038/nn1040 · Cited by 821
“Despite the clinical importance of this complication, little is known about its cause”
BackgroundDuty, S., & Jenner, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01426.x · Cited by 753
The cerebellum in Parkinson’s disease
Wu, T., & Hallett, M. (2013) · Brain · doi:10.1093/brain/aws360 · Cited by 748
Lundblad, M., Andersson, M., Winkler, C., Kirik, D., Wierup, N., & Cenci, M. A. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01843.x · Cited by 664
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Millan, M. J., Maiofiss, L., Cussac, D., Audinot, V., Boutin, J.-A., & Newman-Tancredi, A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039867 · Cited by 484
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
Fabbrini, G., Brotchie, J. M., Grandas, F., Nomoto, M., & Goetz, C. G. (2007) · Movement Disorders · doi:10.1002/mds.21475 · Cited by 464
Self-citationAnimal models of neurological deficits: how relevant is the rat?
Cenci, M. A., Whishaw, I. Q., & Schallert, T. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn877 · Cited by 456
Mallet, N., Ballion, B., Le Moine, C., & Gonon, F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4439-05.2006 · Cited by 413
Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia
Aubert, I., Guigoni, C., Håkansson, K., Li, Q., Dovero, S., Barthe, N., Bioulac, B. H., Gross, C. E., Fisone, G., Bloch, B., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20296 · Cited by 387
Self-citationAttenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
Bézard, E., Ferry, S., Mach, U., Stark, H., Leriche, L., Boraud, T., Gross, C., & Sokoloff, P. (2003) · Nature Medicine · doi:10.1038/nm875 · Cited by 383
Self-citationDopamine, affordance and active inference
Friston, K. J., Shiner, T., FitzGerald, T., Galea, J. M., Adams, R., Brown, H., Dolan, R. J., Moran, R., Stephan, K. E., & Bestmann, S. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002327 · Cited by 381
“However, increasing levels of, or sensitivity to, dopamine in the basal ganglia has been implicated in several movement disorders, including tardive dyskinesia [133], Huntington’s disease [134], Tourette syndrome [135], hemiballismus [136] and levodopa-induced dyskinesia [137].”
BackgroundLimitations of current Parkinson's disease therapy
Rascol, O., Payoux, P., Ory, F., Ferreira, J. J., Brefel-Courbon, C., & Montastruc, J.-L. (2003) · Annals of Neurology · doi:10.1002/ana.10513 · Cited by 337
Voon, V., Fernagut, P.-O., Wickens, J., Baunez, C., Rodriguez, M., Pavon, N., Juncos, J. L., Obeso, J. A., & Bezard, E. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70287-x · Cited by 335
Self-citationSmoking, nicotine and Parkinson's disease
Quik, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.008 · Cited by 324
Novel pharmacological targets for the treatment of Parkinson's disease
Schapira, A. H. V., Bezard, E., Brotchie, J., Calon, F., Collingridge, G. L., Ferger, B., Hengerer, B., Hirsch, E., Jenner, P., Novère, N. L., et al. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2087 · Cited by 298
Self-citationClinical spectrum of levodopa‐induced complications
Aquino, C. C., & Fox, S. H. (2015) · Movement Disorders · doi:10.1002/mds.26125 · Cited by 270
Lindgren, H. S., Andersson, D. R., Lagerkvist, S., Nissbrandt, H., & Cenci, M. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06556.x · Cited by 263
The serotonergic system in Parkinson's disease
Huot, P., Fox, S. H., & Brotchie, J. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.004 · Cited by 195
Self-citationHallett, P. J., Dunah, A. W., Ravenscroft, P., Zhou, S., Bezard, E., Crossman, A. R., Brotchie, J. M., & Standaert, D. G. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.11.008 · Cited by 192
“Abnormal (hyperactive) transmission of the direct striatal output pathway has been implicated in the genesis of LID ( Bezard et al., 2001a ), and it is possible that the enhanced abundance of NR2A observed in the primate reflects the participation of the direct pathway in LID.”
BackgroundSelf-citationHuot, P., Johnston, T. H., Darr, T., Hazrati, L., Visanji, N. P., Pires, D., Brotchie, J. M., & Fox, S. H. (2010) · Movement Disorders · doi:10.1002/mds.23083 · Cited by 153
“This suggests that enhanced 5-HT2A-mediated neurotransmission might underlie the pathophysiology of VH, and 5-HT2A antagonists may be useful in the treatment of VH in PD.”
ResultInfluentialSelf-citationMcNamara, R. K., Logue, A., Stanford, K., Xu, M., Zhang, J., & Richtand, N. M. (2006) · Synapse · doi:10.1002/syn.20315 · Cited by 57
“Dyskinesias are thought to result from behavioral sensitization to L-dopa-induced elevations in DA transmission (Bezard et al., 2001).”
BackgroundParkinson's disease: opportunities for novel therapeutics to reduce the problems of levodopa therapy
FOX, S., CHUANG, R., & BROTCHIE, J. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00923-0 · Cited by 39
Self-citationSharing Practices for Datasets Related to Accessibility and Aging
Kamikubo, R., Dwivedi, U., & Kacorri, H. (2021) · Proceedings of the 23rd International ACM SIGACCESS Conference on Computers and Accessibility · doi:10.1145/3441852.3471208 · Cited by 13
“patients after prolonged treatment with levodopa, often noted as levodopa-induced dyskinesia (LID), causing involuntary and uncontrollable movements [23].”
Background
Metadata
- Authors
- Bezard, E., Brotchie, J. M., & Gross, C. E.
- Venue
- Nature Reviews Neuroscience
- Published
- 2001-08
- Volume
- 2
- Issue
- 8
- Pages
- 577-588
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2017424741
- Cited by
- 503
- References
- 119
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.